国药控股(01099.HK):国药一致2024年度净利润预降52.48%-64.92%

格隆汇
19 Jan

格隆汇1月19日丨国药控股(01099.HK)发布公告,国药一致(000028.SZ)2024年归属于上市公司股东的净利润盈利5.61亿元–7.60亿元(人民币,下同),比上年同期下降52.48%-64.92%;扣除非经常性损益后的净利润盈利4.97亿元–6.96亿元,比上年同期下降54.59%-67.58%;基本每股收益盈利1.01元/股–1.37元/股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10